ALXO Alx Oncology Holdings 

USD 14.21 0.00 0
Icon

Alx Oncology Holdings  (ALXO) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 14.21

0.00 (0.00)%

USD 0.74B

0.20M

USD 18.67(+31.36%)

N/A

Icon

ALXO

Alx Oncology Holdings  (USD)
COMMON STOCK | NSD
USD 14.21
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.74B

N/A

USD 14.21

Alx Oncology Holdings  (ALXO) Stock Forecast

Show ratings and price targets of :
USD 18.67
(+31.36%)

Based on the Alx Oncology Holdings  stock forecast from 5 analysts, the average analyst target price for Alx Oncology Holdings  is USD 18.67 over the next 12 months. Alx Oncology Holdings ’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Alx Oncology Holdings  is Bearish, which is based on 1 positive signals and 8 negative signals. At the last closing, Alx Oncology Holdings ’s stock price was USD 14.21. Alx Oncology Holdings ’s stock price has changed by -12.34% over the past week, -9.72% over the past month and +136.44% over the last year.

No recent analyst target price found for Alx Oncology Holdings 
No recent average analyst rating found for Alx Oncology Holdings 

Company Overview Alx Oncology Holdings 

ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States. The company's lead product candidate is Evorpacept, a CD47 blocking therapeutic biologic in development as a combination therapy with ot...Read More

https://www.alxoncology.com

323 Allerton Avenue, South San Francisco, CA, United States, 94080

72

December

USD

USA

Adjusted Closing Price for Alx Oncology Holdings  (ALXO)

Loading...

Unadjusted Closing Price for Alx Oncology Holdings  (ALXO)

Loading...

Share Trading Volume for Alx Oncology Holdings  Shares

Loading...

Compare Performance of Alx Oncology Holdings  Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ALXO

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Alx Oncology Holdings  (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc 0.00 (0.00%) USD109.10B 27.47 20.00

ETFs Containing ALXO

Symbol Name ALXO's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Alx Oncology Holdings  (ALXO) Stock

Based on ratings from 5 analysts Alx Oncology Holdings 's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 5 buy, sell and 1 hold ratings.

Unfortunately we do not have enough data on ALXO's stock to indicate if its a good dividend stock.

Based on targets from 5 analysts, the average taret price for ALXO is USD 18.67 over the next 12 months. The maximum analyst target price is USD 21 while the minimum anlayst target price is USD 14.

ALXO stock's Price/Earning ratio is -99,999.99. Our analysis grades ALXO stock's Price / Earning ratio at A+. This means that ALXO stock's Price/Earning ratio is above 1.000000000000001% of the stocks in the Biotechnology sector in the NSD exchange. Based on this ALXO may be undervalued for its sector.

The last closing price of ALXO's stock was USD 14.21.

The most recent market capitalization for ALXO is USD 0.74B.

Based on targets from 5 analysts, the average taret price for ALXO is projected at USD 18.67 over the next 12 months. This means that ALXO's stock price may go up by +31.36% over the next 12 months.

We can't find any ETFs which contains Alx Oncology Holdings 's stock.

As per our most recent records Alx Oncology Holdings  has 72 Employees.

Alx Oncology Holdings 's registered address is 323 Allerton Avenue, South San Francisco, CA, United States, 94080. You can get more information about it from Alx Oncology Holdings 's website at https://www.alxoncology.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...